Your browser doesn't support javascript.
loading
A randomized, triple-blinded controlled clinical study with a novel disease-modifying drug combination in equine lameness-associated osteoarthritis.
Skiöldebrand, E; Adepu, S; Lützelschwab, C; Nyström, S; Lindahl, A; Abrahamsson-Aurell, K; Hansson, E.
Affiliation
  • Skiöldebrand E; Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden.
  • Adepu S; Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden.
  • Lützelschwab C; Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden.
  • Nyström S; Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, Sahlgrenska University Hospital, Gothenburg University, Gothenburg, Sweden.
  • Lindahl A; Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, Sahlgrenska University Hospital, Gothenburg University, Gothenburg, Sweden.
  • Abrahamsson-Aurell K; Hallands Djursjukhus Kungsbacka Hästklinik, Älvsåkers Byväg 20, 434 95 Kungsbacka, Sweden.
  • Hansson E; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Osteoarthr Cartil Open ; 5(3): 100381, 2023 Sep.
Article in En | MEDLINE | ID: mdl-37416846

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Language: En Journal: Osteoarthr Cartil Open Year: 2023 Document type: Article Affiliation country: Sweden

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Language: En Journal: Osteoarthr Cartil Open Year: 2023 Document type: Article Affiliation country: Sweden